Skip to main content

Sporotrichosis

  • Chapter
  • First Online:
Diagnosis and Treatment of Fungal Infections

Abstract

Sporotrichosis is a subacute to chronic fungal infection of skin and subcutaneous tissues. The causative agent, Sporothrix schenckii, is a dimorphic fungus that exists as a mold in the environment and as a yeast in tissues. S. schenckii is not a single species, but rather a complex of at least 6 phylogenetically different organisms. In the environment, S. schenckii is found in sphagnum moss, decaying wood, vegetation, hay, and soil. Infection occurs when a person is exposed to an environmental source, and the organism is inoculated through the skin. A large continuing outbreak in Rio de Janeiro is associated with zoonotic transmission from infected cats.

The most common manifestation of sporotrichosis is lymphocutaneous or localized cutaneous infection. Pulmonary sporotrichosis mimics reactivation tuberculosis and occurs most often in those who have chronic obstructive pulmonary disease. Osteoarticular sporotrichosis is uncommon and is found most often in middle-aged men. Disseminated and meningeal sporotrichosis are very uncommon; almost all patients have cellular immune deficiencies, and most cases are in persons with AIDS. Most patients who have sporotrichosis can be successfully treated with oral itraconazole although saturated solution of potassium iodide (SSKI) is still used in some countries. Those patients who have disseminated infection, meningitis, or severe pulmonary involvement should be treated initially with an intravenous amphotericin B formulation before transitioning to itraconazole.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Chakrabati A, Bonifaz A, Gutierrez-Galhardo MC, Mochizuki T, Li S. Global epidemiology of sporotrichosis. Med Mycol. 2015;53:2–14.

    Google Scholar 

  2. Rossow JA, Queiroz-Telles F, Caceres DH, et al. A one health approach to combatting Sporothrix brasiliensis: narrative review of an emerging zoonotic fungal pathogen in South America. J Fungi. 2020;6:247. https://doi.org/10.3390/jof6040247.

    Article  CAS  Google Scholar 

  3. Marimon R, Gené J, Cano J, et al. Molecular phylogeny of Sporothrix schenckii. J Clin Microbiol. 2006;44:3251–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Marimon R, Cano J, Gené J, et al. Sporothrix brasiliensis, S. globosa, and S. mexicana, three new Sporothrix species of clinical interest. J Clin Microbiol. 2007;45:3198–206.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Rodrigues AM, deHoog S, Camargo ZP. Emergence of pathogenicity in the Sporothrix schenckii complex. Med Mycol. 2013;51:405–12.

    Article  PubMed  Google Scholar 

  6. López-Romero E, Reyes-Montes M, Pérez-Torres A, et al. Sporothrix schenckii complex and sporotrichosis, an emerging health problem. Future Microbiol. 2011;6:85–102.

    Article  PubMed  Google Scholar 

  7. Rangel-Gamboa L, Martínez-Hernandez F, Maravilla P, Arenas-Guzmán R, Flisser A. Update of phylogenetic and genetic diversity of Sporothrix schenckii sensu lato. Med Mycol. 2016;54:248–55.

    Article  CAS  PubMed  Google Scholar 

  8. Li J, Zhan P, Jiang Q, et al. Prevalence and antifungal susceptibility of Sporothrix species in Jiangxi, Central China. Med Mycol. 2019;57:951–61.

    Article  Google Scholar 

  9. Barros MBL, de Almeida PR, Achubach AO. Sporothrix and sporotrichosis. Clin Microbiol Rev. 2011;24:633–54.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Dixon DM, Salkin IF, Duncan RA, et al. Isolation and characterization of Sporothrix schenckii from clinical and environmental sources associated with the largest U.S. epidemic of sporotrichosis. J Clin Microbiol. 1991;29:1106–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Zhang X, Andrews JH. Evidence for growth of Sporothrix schenckii on dead but not on living sphagnum moss. Mycopathologia. 1993;123:87–94.

    Article  CAS  PubMed  Google Scholar 

  12. Pappas PG, Tellez I, Deep AE, et al. Sporotrichosis in Peru: description of an area of hyperendemicity. Clin Infect Dis. 2000;30:65–70.

    Article  CAS  PubMed  Google Scholar 

  13. Lyon GM, Zurita S, Casquero J, et al. Population-based surveillance and a case-control study of risk factors for endemic lymphocutaneous sporotrichosis in Peru. Clin Infect Dis. 2003;36:34–9.

    Article  CAS  PubMed  Google Scholar 

  14. Conti Díaz IA. Epidemiology of sporotrichosis in Latin America. Mycopathologia. 1989;108:113–6.

    Article  PubMed  Google Scholar 

  15. Reed KD, Moore FM, Geiger GE, Stemper ME. Zoonotic transmission of sporotrichosis: case report and review. Clin Infect Dis. 1993;16:384–7.

    Article  CAS  PubMed  Google Scholar 

  16. Cooper CR, Dixon DM, Salkin IF. Laboratory-acquired sporotrichosis. J Med Vet Mycol. 1992;30:169–71.

    Article  CAS  PubMed  Google Scholar 

  17. Powell KE, Taylor A, Phillips BJ, et al. Cutaneous sporotrichosis in forestry workers. Epidemic due to contaminated sphagnum moss. JAMA. 1978;240:232–5.

    Article  CAS  PubMed  Google Scholar 

  18. Hajjeh R, McDonnell S, Reef S, et al. Outbreak of sporotrichosis among tree nursery workers. J Infect Dis. 1997;76:499–504.

    Article  Google Scholar 

  19. Dooley DP, Bostic PS, Beckius ML, Spook house sporotrichosis. A point-source outbreak of cutaneous sporotrichosis from hay bale props in a Halloween haunted-house. Arch Intern Med. 1997;157:1885–7.

    Article  CAS  PubMed  Google Scholar 

  20. Barros MB, Schubach AO, do Valle AC, et al. Cat-transmitted sporotrichosis epidemic in Rio de Janeiro, Brazil: description of a series of cases. Clin Infect Dis. 2004;38:529–35.

    Article  PubMed  Google Scholar 

  21. Kovarik CL, Neyra E, Bustamante B. Evaluation of cats as the source of endemic sporotrichosis in Peru. Med Mycol. 2008;46:53–6.

    Article  PubMed  Google Scholar 

  22. Galhardo MC, De Oliveira RM, do Valle AC, et al. Molecular epidemiology and antifungal susceptibility patterns of Sporothrix schenckii isolates from a cat-transmitted epidemic of sporotrichosis in Rio de Janeiro, Brazil. Med Mycol. 2008;46:141–51.

    Article  CAS  PubMed  Google Scholar 

  23. Leme LRP, Schubach TM, Santos IB, et al. Mycological evaluation of bronchoalveolar lavage in cats with respiratory signs from Rio de Janeiro, Brazil. Mycoses. 2007;50:210–4.

    Article  CAS  PubMed  Google Scholar 

  24. Schubach TM, Schubach A, Okamoto T, et al. Canine sporotrichosis in Rio de Janeiro, Brazil: clinical presentation, laboratory diagnosis, and therapeutic response in 44 cases (1998-2003). Med Mycol. 2006;44:87–92.

    Article  PubMed  Google Scholar 

  25. Teixeira PAC, de Castro RA, Nascimento RC, et al. Cell surface expression of adhesins for fibronectin correlates with virulence in Sporothrix schenckii. Microbiology. 2009;155:3730–8.

    Article  CAS  PubMed  Google Scholar 

  26. Nascimento RC, Espíndola NM, Castro RA, et al. Passive immunization with monoclonal antibody against a 70-kDa putative adhesin of Sporothrix schenckii induces protection in murine sporotrichosis. Eur J Immunol. 2008;38:3080–9.

    Article  CAS  PubMed  Google Scholar 

  27. Castro RA, Kubitschek-Barreira PH, Teixeira PA, et al. Differences in cell morphometry, cell wall topography, and gp70 expression correlate with the virulence of Sporothrix brasiliensis clinical isolates. PloS One. 2013;8:e75656.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Madrid IM, Xavier MO, Mattei AS, et al. Role of melanin in the pathogenesis of cutaneous sporotrichosis. Microbes Infect. 2010;12:162–5.

    Article  CAS  PubMed  Google Scholar 

  29. Negrini TC, Ferreira LS, Alegranci P, et al. Role of TLR-2 and fungal surface antigens on innate immune response against Sporothrix schenckii. Immunol Invest. 2013;42:36–48.

    Article  CAS  PubMed  Google Scholar 

  30. Ferreira LS, Goncalves AC, Portuondo DL, et al. Optimal clearance of Sporothrix schenckii requires an intact Th17 response in a mouse model of systemic infection. Immunobiology. 2015;220:985–92.

    Article  CAS  PubMed  Google Scholar 

  31. Jellmayer JA, Ferreira LS, Manente FA, et al. Dectin-1 expression by macrophages and related antifungal mechanisms in a murine model of Sporothrix schenckii sensu stricto system infection. Microb Pathog. 2017;110:78–84.

    Article  CAS  PubMed  Google Scholar 

  32. Tachibana T, Matsuyama T, Mitsuyama M. Involvement of CD4+ T cells and macrophages in acquired protection against infection with Sporothrix schenckii in mice. Med Mycol. 1999;37:397–404.

    Article  CAS  PubMed  Google Scholar 

  33. Queiroz-Telles F, Buccheri R, Benard G. Sporotrichosis in immunocompromised hosts. J Fungi. 2019;5:8. https://doi.org/10.3390/jof5010009.

    Article  CAS  Google Scholar 

  34. Freitas DF, de Siqueira HB, do Valle AC, et al. Sporotrichosis in HIV-infected patients: report of 21 cases of endemic sporotrichosis in Rio de Janeiro, Brazil. Med Mycol. 2012;50:170–8.

    Article  PubMed  Google Scholar 

  35. Bustamante B, Lama JR, Mosquera C, Soto L. Sporotrichosis in human immunodeficiency virus infected Peruvian patients. Infect Dis Clin Pract. 2009;17:78–83.

    Article  Google Scholar 

  36. da Silva RF, Bonfitto M, da Silva Junior FIM, de Ameida MTG, da Silva RC. Sporotrichosis in a liver transplant patient: a case report and literature review. Mycol Case Rep. 2017;17:25–7.

    Article  Google Scholar 

  37. Gewehr P, Jung B, Aquino V, et al. Sporotrichosis in renal transplant patients. Can J Infect Dis Med Microbiol. 2013;24:e47–9.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Gullberg RM, Quintanilla A, Levine ML, Williams J, Phair JP. Sporotrichosis: recurrent cutaneous, articular, and central nervous system infection in a renal transplant recipient. Rev Infect Dis. 1987;9:369–75.

    Article  CAS  PubMed  Google Scholar 

  39. Bunce PE, Yang L, Chun S, et al. Disseminated sporotrichosis in a patient with hairy cell leukemia treated with amphotericin B and posaconazole. Med Mycol. 2012;50:197–201.

    Article  CAS  PubMed  Google Scholar 

  40. Gottlieb GS, Lesser CF, Holmes KK, Wald A. Disseminated sporotrichosis associated with treatment with immunosuppressants and tumor necrosis factor–alpha antagonists. Clin Infect Dis. 2003;37:638–40.

    Article  Google Scholar 

  41. Ursini F, Russo E, Leporini C, et al. Lymphocutaneous sporotrichosis during treatment with anti-TNF-alpha monotherapy. Case Rep Rheumatol. 2015;2015:614504.

    PubMed  PubMed Central  Google Scholar 

  42. Kauffman CA. Sporotrichosis. Clin Infect Dis. 1999;29:231–7.

    Article  CAS  PubMed  Google Scholar 

  43. Benvegnu AM, Stramari J, Dallazem LND, Chemello RMI, Beber AAC. Disseminated cutaneous sporotrichosis in a patient with alcoholism. Rev Soc Bras Med Trop. 2017;50:871–3.

    Article  PubMed  Google Scholar 

  44. Aung A, Spelman D, Thompson P. Pulmonary sporotrichosis: an evolving clinical paradigm. Semin Respir Crit Care Med. 2015;36:756–66.

    Article  PubMed  Google Scholar 

  45. Aung AK, Teh MB, McGrath C, Thompson PJ. Pulmonary sporotrichosis: case series and systematic analysis of literature on clinico-radiological patterns and management outcomes. Med Mycol. 2013;51:534–44.

    Article  PubMed  Google Scholar 

  46. Smego RA, Castiglia M, Asperilla MO. Lymphocutaneous syndrome. A review of non-Sporothrix causes. Medicine (Baltimore). 1999;78:38–63.

    Article  PubMed  Google Scholar 

  47. Tirado- Sánchez A, Bonifaz A. Nodular lymphangitis (sporotrichoid lymphocutaneous infections): clues to differential diagnosis. J Fungi. 2018;4:56. https://doi.org/10.3390/jof4020056.

    Article  CAS  Google Scholar 

  48. Pluss JL, Opal SM. Pulmonary sporotrichosis: review of treatment and outcome. Medicine (Baltimore). 1986;65:143–53.

    Article  CAS  PubMed  Google Scholar 

  49. Tiwari A, Malani AN. Primary pulmonary sporotrichosis. Case report and review of the literature. Infect Dis Clin Pract. 2012;20:25–7.

    Article  Google Scholar 

  50. Rojas FD, Fernandez MS, Lucchelli JM, et al. Cavitary pulmonary sporotrichosis: case report and literature review. Mycopathologia. 2017;182:1119–23.

    Article  PubMed  Google Scholar 

  51. Winn RE, Anderson J, Piper J, Aronson NE, Pluss J. Systemic sporotrichosis treated with itraconazole. Clin Infect Dis. 1993;17:210–7.

    Article  CAS  PubMed  Google Scholar 

  52. Lesperance M, Baumgartner D, Kauffman CA. Arthritis due to Sporothrix schenckii. Mycoses. 1988;31:599–603.

    Article  CAS  PubMed  Google Scholar 

  53. Lipstein-Kresch E, Isenberg HD, Singer C, Cooke O, Greenwald RA. Disseminated Sporothrix schenckii infection with arthritis in a patient with acquired immunodeficiency syndrome. J Rheumatol. 1985;12:805–8.

    CAS  PubMed  Google Scholar 

  54. Atdjian M, Granda JL, Ingberg HO, Kaplan BL. Systemic sporotrichosis polytenosynovitis with median and ulnar nerve entrapment. JAMA. 1980;243:1841–2.

    Article  CAS  PubMed  Google Scholar 

  55. Kauffman CA. Central nervous system infection with other endemic mycoses: rare manifestation of blastomycosis, paracoccidioidomycosis, talaromycosis, and sporotrichosis. J Fungi. 2019;5:64. https://doi.org/10.3390/jof5030064.

    Article  CAS  Google Scholar 

  56. Shoemaker EH, Bennett HD, Fields WS, Whitcomb FC, Halpert B. Leptomeningitis due to Sporotrichum schenckii. AMA Arch Pathol. 1957;64:222–7.

    CAS  PubMed  Google Scholar 

  57. Hessler C, Kauffman CA, Chow FC. The upside of bias: a case of chronic meningitis due to Sporothrix schenckii in an immunocompetent host. Neurohospitalist. 2017;7:30–4.

    Article  PubMed  Google Scholar 

  58. Mialski R, de Almeida JN Jr, da Silva LH, et al. Chronic meningitis and hydrocephalus due to Sporothrix brasiliensis in immunocompetent adults: a challenging entity. Open Forum Infect Dis. 2018;5:ofy081. https://doi.org/10.1093/ofid/ofy081.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Donabedian H, O’Donnell E, Olszewski C, MacArthur RD, Budd N. Disseminated cutaneous and meningeal sporotrichosis in an AIDS patient. Diagn Microbiol Infect Dis. 1994;18:111–5.

    Article  CAS  PubMed  Google Scholar 

  60. Freitas DFS, Lima MA, de Almeida-Paes R, et al. Sporotrichosis in the central nervous system caused by Sporothrix brasiliensis. Clin Infect Dis. 2015;61:663–4.

    Article  PubMed  Google Scholar 

  61. Bonifaz A, Tirado-Sanchez A. Cutaneous disseminated and extracutaneous sporotrichosis: current status of a complex disease. J Fungi. 2017;3:6. https://doi.org/10.3390/jof3010006.

    Article  CAS  Google Scholar 

  62. Al-Tawfiq JA, Wools KK. Disseminated sporotrichosis and Sporothrix schenckii fungemia as the initial presentation of human immunodeficiency virus infection. Clin Infect Dis. 1998;26:1403–6.

    Article  CAS  PubMed  Google Scholar 

  63. Castrejón OV, Robles M, Zubieta Arroyo OE. Fatal fungaemia due to Sporothrix schenckii. Mycoses. 1995;38:373–6.

    Article  PubMed  Google Scholar 

  64. Almeida-Paes R, de Oliveira MME, Freitas DF, et al. Sporotrichosis in Rio de Janeiro, Brazil: Sporothrix brasiliensis is associated with atypical clinical presentations. PLoS Negl Trop Dis. 2014;8:e3094.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Arenas R, Sánchez-Cardenas CD, Ramirez-Hobak L, Ruiz Arriga LF, Vega Memije ME. Sporotrichosis: from KOH to molecular biology. J Fungi. 2018;4:62. https://doi.org/10.3391/jof4020062.

    Article  Google Scholar 

  66. Rudramurthy SM, Chakrabarti A. Sporotrichosis: update on diagnostic techniques. Curr Fungal Infect Rep. 2017;11:134–40.

    Article  Google Scholar 

  67. Oliveira MM, Santos C, Sampaio P, et al. Development and optimization of a new MALDI-TOF protocol for identification of the Sporothrix species complex. Res Microbiol. 2015;166:102–10.

    Article  PubMed  Google Scholar 

  68. Quintella LP, Passos SR, do Valle AC, et al. Histopathology of cutaneous sporotrichosis in Rio de Janeiro: a series of 119 consecutive cases. J Cutan Pathol. 2011;38:25–32.

    Article  PubMed  Google Scholar 

  69. Hussein MR. Mucocutaneous Splendore-Hoeppli phenomenon. J Cutan Pathol. 2008;35:979–88.

    Article  PubMed  Google Scholar 

  70. Bernardes-Engemann AR, de Lima BM, Zeitune T, Russi DC, Orofino-Costa R, Lopes-Bezerra LM. Validation of a serodiagnostic test for sporotrichosis: a follow-up study of patients related to the Rio de Janeiro zoonotic outbreak. Med Mycol. 2015;53:28–33.

    Article  PubMed  Google Scholar 

  71. Alvarado P, Ostos A, Franquiz N, Roschman-Gonzalez A, Zambrano EA, Mendoza M. Serological diagnosis of sporotrichosis using an antigen of Sporothrix schenckii sensu stricto mycelium. Invest Clin. 2015;56:111–22.

    PubMed  Google Scholar 

  72. Hu S, Chung W-H, Hung S-I, et al. Detection of Sporothrix schenckii in clinical samples by a nested PCR assay. J Clin Microbiol. 2003;41:1414–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Xu TH, Lin JP, Gao XH, Wei H, Liao W, Chen HD. Identification of Sporothrix schenckii of various mtDNA types by nested PCR assay. Med Mycol. 2010;48:161–5.

    Article  CAS  PubMed  Google Scholar 

  74. Liu X, Zhang Z, Hou B, et al. Rapid identification of Sporothrix schenckii in biopsy tissue by PCR. J Eur Acad Dermatol Venereol. 2013;27:1491–7.

    Article  CAS  PubMed  Google Scholar 

  75. Kauffman CA, Bustamante B, Chapman SW, Pappas PG. Clinical practice guidelines for the management of patients with sporotrichosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis. 2007;45:1255–65.

    Article  CAS  PubMed  Google Scholar 

  76. Thompson GR, Thuy L, Chindamporn A, et al. Global guideline for the diagnosis and management of the endemic mycoses. Lancet Infect Dis. 2021;21:e364–74.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Marimon R, Serena C, Gené J, Cano J, Guarro J. In vitro susceptibilities of five species of Sporothrix. Antimicrob Agents Chemother. 2008;52:732–4.

    Article  CAS  PubMed  Google Scholar 

  78. Oliveira DC, Lopes PG, Spader TB, et al. Antifungal susceptibilities of Sporothrix albicans, S. brasiliensis, and S. luriei of the S. schenckii complex identified in Brazil. J Clin Microbiol. 2011;49:3047–9.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Rodrigues AM, de Hoog GS, de Cássia PD, et al. Genetic diversity and antifungal susceptibility profiles in causative agents of sporotrichosis. BMC Infect Dis. 2014;14:219–27.

    Article  PubMed  PubMed Central  Google Scholar 

  80. Espinel-Ingroff A, Abreu DPB, Almeida-Paes R, et al. Multicenter, international study of MIC/MEC distributions for definition of epidemiological cutoff values for Sporothrix species identified by molecular methods. Antimicrob Agents Chemother. 2017;61:e01057–17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  81. de Lima Barros MB, Schubach AO, Carvalhaes de Oliveira R, Martins EB, Teixeira JL, Wanke B. Treatment of cutaneous sporotrichosis with itraconazole—study of 645 patients. Clin Infect Dis. 2011;52:e200–6.

    Article  PubMed  Google Scholar 

  82. Sharkey-Mathis PK, Kauffman CA, Graybill JR, et al. Treatment of sporotrichosis with itraconazole. Am J Med. 1993;95:279–85.

    Article  CAS  PubMed  Google Scholar 

  83. Restrepo A, Robledo J, Gomez I, Tabares AM, Gutierrez R. Itraconazole therapy in lymphangitic and cutaneous sporotrichosis. Arch Dermatol. 1986;122:413–7.

    Article  CAS  PubMed  Google Scholar 

  84. Rex JH, Bennett JE. Administration of potassium iodide to normal volunteers does not increase killing of Sporothrix schenckii by their neutrophils and monocytes. J Med Vet Mycol. 1990;28:185–9.

    Article  CAS  PubMed  Google Scholar 

  85. Sterling JB, Heymann WR. Potassium iodide in dermatology: a 19th century drug for the 21st century-uses, pharmacology, adverse effects, and contraindications. J Am Acad Dermatol. 2000;43:691–7.

    Article  CAS  PubMed  Google Scholar 

  86. Macedo PM, Lopes-Bezerra LM, Bernardes-Engemann AR, Orofino-Costa R. New posology of potassium iodide for the treatment of cutaneous sporotrichosis: study of efficacy and safety in 102 patients. J Eur Acad Dermatol Venereol. 2015;29:719–24.

    Article  CAS  PubMed  Google Scholar 

  87. Chapman SW, Pappas P, Kauffman C, et al. Comparative evaluation of the efficacy and safety of two doses of terbinafine (500 and 1000 mg day−1) in the treatment of cutaneous or lymphocutaneous sporotrichosis. Mycoses. 2003;47:62–8.

    Article  Google Scholar 

  88. Francesconi G, do Valle AC, Passos SL, et al. Comparative study of 250 mg/day terbinafine and 100 mg/day itraconazole for the treatment of cutaneous sporotrichosis. Mycopathologia. 2011;171:349–54.

    Article  CAS  PubMed  Google Scholar 

  89. Kauffman CA, Pappas PG, McKinsey DS, et al. Treatment of lymphocutaneous and visceral sporotrichosis with fluconazole. Clin Infect Dis. 1996;22:46–50.

    Article  CAS  PubMed  Google Scholar 

  90. Fernández-Silva F, Capilla J, Mayayo E, Guarro J. Efficacy of posaconazole in murine experimental sporotrichosis. Antimicrob Agents Chemother. 2012;56:2273–7.

    Article  PubMed  PubMed Central  Google Scholar 

  91. He Y, Ma C, Fung M, Fitzmaurice S. Disseminated cutaneous sporotrichosis presenting as a necrotic facial mass: case and review. Dermatol Online J. 2017;23:10.

    Article  Google Scholar 

  92. Thomson J, Trott DJ, Malik R, et al. An atypical case of sporotrichosis in a cat. Med Mycol Case Rep. 2019;23:72–6.

    Article  PubMed  PubMed Central  Google Scholar 

  93. Paixão AG, Galhardo MCG, Almeida-Paes R, et al. The difficult management of disseminated Sporothrix brasiliensis in a patient with advanced AIDS. AIDS Res Ther. 2015;12:16. https://doi.org/10.1186/s12981-015-0051-1.

    Article  PubMed  PubMed Central  Google Scholar 

  94. Hiruma M, Kagawa S. The effects of heat on Sporothrix schenckii in vitro and in vivo. Mycopathologia. 1998;84:21–30.

    Article  Google Scholar 

  95. Hiruma M, Kawada A, Noguchi H, Ishibashi A, Conti Diaz IA. Hyperthermic treatment of sporotrichosis: experimental use of infrared and far infrared rays. Mycoses. 1992;35:293–9.

    Article  CAS  PubMed  Google Scholar 

  96. Downs NJ, Hinthorn DR, Mhatre VR, Liu C. Intra-articular amphotericin B treatment of Sporothrix schenckii arthritis. Arch Intern Med. 1989;149:954–5.

    Article  CAS  PubMed  Google Scholar 

Further Reading

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Carol A. Kauffman .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kauffman, C.A., Miceli, M.H. (2023). Sporotrichosis. In: Hospenthal, D.R., Rinaldi, M.G., Walsh, T.J. (eds) Diagnosis and Treatment of Fungal Infections. Springer, Cham. https://doi.org/10.1007/978-3-031-35803-6_22

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-35803-6_22

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-35802-9

  • Online ISBN: 978-3-031-35803-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics